News & Updates

Only a minority of patients are considered fully recovered 1 year after being discharged from hospital due to COVID-19, with women and obese individuals at increased risk of long COVID, according to results of the prospective PHOSP-COVID* study presented at ECCMID 2022 and published in The Lancet.

A recent study has demonstrated the importance of gastrointestinal (GI) symptoms as a clinical morbidity and that these symptoms are associated with increasing age, duration of type 1 diabetes (T1D), haemoglobin A1c (HbA1c), and microvascular complications, but not with autoimmune comorbidities including coeliac disease (CD).

Young, premenopausal women with long or irregular menstrual cycles are at an increased risk of both prevalent and incident nonalcoholic fatty liver disease (NAFLD), reveals a study.

People with hypothyroidism and lower free thyroxine (FT4) levels in the reference range have a higher risk of type 2 diabetes (T2D), suggests a recent study.

Intensive management of blood pressure (BP) leads to a significant reduction in cardiovascular events in overweight, obese I, and obese II patients without elevating safety risks, a study has shown.

A diet rich in fat but low in carbohydrates, popularly known as the ketogenic or “keto” diet, offers clinical benefits to patients with relapsing multiple sclerosis (MS) in a phase II study. Quality of life (QoL) likewise improved, and so did disability.

A recent meta-analysis offers new proof of different canagliflozin doses for hypertension management in patients with type 2 diabetes mellitus (T2DM) complicated by hypertension. However, low-density lipoprotein cholesterol (LDL-C) and the risk of urinary tract infection must be observed.